Blood test to help diagnose ovarian cancer sooner
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study checks whether a special blood test (circulating tumor DNA) can help find ovarian cancer when it’s suspected. It may help doctors diagnose more accurately and sooner, so the right treatment can start sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You currently have suspected ovarian cancer (ovarian growth found or strong concern it could be cancer).
- You can understand the study and give informed consent.
- You have never been told you had ovarian cancer before.
- If you cannot give consent, you cannot join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects a blood sample before you have surgery or a biopsy for an ovarian mass. Researchers will test whether a new blood test can accurately identify ovarian cancer by looking at DNA patterns in your blood. The results will help doctors understand if this blood test could help detect ovarian cancer earlier in the future.
This study tests a new blood test to help doctors determine if an ovarian mass is cancerous before surgery. If you are a woman over 18 with an ovarian cyst or mass that needs surgery, this test could help guide your care.
This trial looks at tiny molecules in the blood to help diagnose ovarian germ cell tumors. It compares results from people with malignant (cancerous) tumors, benign (non-cancerous) tumors, and those without any gynecologic condition.
This study tests genetic (DNA) information to help doctors identify ovarian or uterine (endometrial) cancer sooner. You may be asked to do this around the time of planned surgery, when tissue is removed and can be checked for genetic clues.
This study looks for early signs of ovarian cancer in a simple blood test. It may help people with BRCA gene changes catch problems sooner, before or after preventive surgery.
This study checks whether a sample of fluid from the uterus (uterine lavage) can help detect ovarian or fallopian tube cancer. You may join if you are having certain gynecologic surgeries or, in a smaller group, you have a BRCA1/2 mutation.
Hear when a new Ovarian Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.